Pharmacological Management of Chronic Obstructive Lung Disease (COPD). Evidence from a Real-World Perspective - Part 2.


Journal

Current medicinal chemistry
ISSN: 1875-533X
Titre abrégé: Curr Med Chem
Pays: United Arab Emirates
ID NLM: 9440157

Informations de publication

Date de publication:
2019
Historique:
received: 16 06 2016
revised: 02 08 2017
accepted: 02 04 2018
pubmed: 1 11 2018
medline: 16 7 2019
entrez: 1 11 2018
Statut: ppublish

Résumé

We report a comprehensive overview of current COPD therapies from a real-world experience. Critically review the opportunities and the challenges occurring in the real-world treatment of COPD. This is a review that also report results from COPD patients treated with standardized therapy including pulmonary rehabilitation (Real World Data - RWD). Comprehensive assessment of COPD management requires strategies able to evaluate efficacy and usefulness in a real-world population, that take into account the interaction between experience and academic training, research, adherence to guidelines and judgments in order to plan the appropriate and optimum use of available strategies.

Sections du résumé

BACKGROUND BACKGROUND
We report a comprehensive overview of current COPD therapies from a real-world experience.
OBJECTIVE OBJECTIVE
Critically review the opportunities and the challenges occurring in the real-world treatment of COPD.
METHODS METHODS
This is a review that also report results from COPD patients treated with standardized therapy including pulmonary rehabilitation (Real World Data - RWD).
CONCLUSION CONCLUSIONS
Comprehensive assessment of COPD management requires strategies able to evaluate efficacy and usefulness in a real-world population, that take into account the interaction between experience and academic training, research, adherence to guidelines and judgments in order to plan the appropriate and optimum use of available strategies.

Identifiants

pubmed: 30378484
pii: CMC-EPUB-94119
doi: 10.2174/0929867325666181031101128
doi:

Types de publication

Journal Article Multicenter Study Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1734-1745

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Aliaksei Kisialiou (A)

Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Pisana, Via di Valcannuta, 247, I-00166 Rome, Italy.

Giulia Prinzi (G)

Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Pisana, Via di Valcannuta, 247, I-00166 Rome, Italy.

Palma Lamonaca (P)

Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Pisana, Via di Valcannuta, 247, I-00166 Rome, Italy.

Vittorio Cardaci (V)

Unit of Pulmonary Rehabilitation, IRCCS San Raffaele Pisana, Via della Pisana, 235, 00163 Rome, Italy.

Carlo Tomino (C)

Scientific Direction, IRCCS San Raffaele Pisana Via di Valcannuta, 247, I-00166 Rome, Italy.

Massimo Fini (M)

Scientific Direction, IRCCS San Raffaele Pisana Via di Valcannuta, 247, I-00166 Rome, Italy.

Stefano Bonassi (S)

Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Pisana, Via di Valcannuta, 247, I-00166 Rome, Italy.

Patrizia Russo (P)

Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Pisana, Via di Valcannuta, 247, I-00166 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH